Clinical Trials · NCT07370922
Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ain Shams University
- Enrollment
- 80
- Start date
- Nov 2024
- Locations
- 1 site, Egypt
- Primary endpoint
- Change in glycemic variability using continuous glucose monitoring after 6 months.